Cargando…
Treatment of Metastatic Gastrointestinal Stromal Tumors (GIST): A Focus on Older Patients
Gastrointestinal stromal tumors (GIST) originating in the Cajal cells are the most common mesenchymal neoplasms of the gastrointestinal tract. The median age of patients with this diagnosis is 65 years, and over 20% of cases affect people over the age of 70 years. The effectiveness and tolerability...
Autores principales: | Dudzisz-Śledź, Monika, Bylina, Elżbieta, Teterycz, Paweł, Rutkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096750/ https://www.ncbi.nlm.nih.gov/pubmed/33651369 http://dx.doi.org/10.1007/s40266-021-00841-x |
Ejemplares similares
-
Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients
por: Dudzisz-Śledź, Monika, et al.
Publicado: (2022) -
The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017) -
Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies
por: Stachyra, Karolina, et al.
Publicado: (2021) -
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
por: Rutkowski, Piotr, et al.
Publicado: (2012) -
When is a GIST not a GIST? A case report of synchronous metastatic gastrointestinal stromal tumor and fibromatosis
por: Lee, Chee Khoon, et al.
Publicado: (2009)